Key facts
- This page summarizes Tyson Rossi's Form 3 filing for MedMen Enterprises, Inc..
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 26 Jan 2022, 18:08.
Tyson Rossi - 10 Jan 2022 Form 3 Insider Report for MedMen Enterprises, Inc.
- Reporting relationship
- Ch. Strategy Officer
- Issuer ticker
- N/A
- Reported as of
- 10 Jan 2022
- Net transaction value
- $0
- Reporting owner signature
- /s/ Tyson Rossi
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Tyson Rossi filed Form 3 for MedMen Enterprises, Inc. on 26 Jan 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MMNFF
holding
Class B Subordinate Voting Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 13,277
- Date
- 10 Jan 2022
- Ownership
- Direct
- Footnotes
- F1
MMNFF
holding
Class B Subordinate Voting Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 262,971
- Date
- 10 Jan 2022
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MMNFF
holding
Derivative
Employee Stock Options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 10 Jan 2022
- Ownership
- Direct
- Underlying class
- Class B Subordinate Voting Shares
- Underlying amount
- 10,000
- Exercise price
- $1.99
- Footnotes
- F3, F4
MMNFF
holding
Derivative
Employee Stock Options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 10 Jan 2022
- Ownership
- Direct
- Underlying class
- Class B Subordinate Voting Shares
- Underlying amount
- 4,530
- Exercise price
- $0.1670
- Footnotes
- F3, F5
MMNFF
holding
Derivative
Employee Stock Options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 10 Jan 2022
- Ownership
- Direct
- Underlying class
- Class B Subordinate Voting Shares
- Underlying amount
- 66,213
- Exercise price
- $0.2814
- Footnotes
- F3, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Represents restricted stock units ("RSUs"), granted 9/9/2020 pursuant to Issuer's 2018 Stock and Incentive Plan (the "Incentive Plan"), which vest annually over four years with 37.5% vesting on 6/30/2021 and 6/30/2023, and 12.5% vesting on 6/30/2022 and 6/30/24. RSUs are equivalent to Issuer's Class B Subordinate Voting Shares and may be settled solely by delivery of an equal number of Shares.
Footnote F2
Represents RSUs granted 8/29/2021 pursuant to the Incentive Plan, which vest annually over four years with 37.5% vesting on 6/30/2022 and 6/30/2024, and 12.5% vesting on 6/30/2023 and 6/30/25. RSUs are equivalent to Issuer's Class B Subordinate Voting Shares and may be settled solely by delivery of an equal number of Shares.
Footnote F3
Employee stock options (right to buy) ("Options") granted pursuant to the Incentive Plan.
Footnote F4
Options have an exercise price of CAN$2.64, which is equivalent to US$1.9858 at an exchange rate of 0.7522 as of the grant date.
Footnote F5
Options have an exercise price of CAN$0.22, which is equivalent to US$0.1670 at an exchange rate of 0.7591 as of the grant date.
Footnote F6
Options have an exercise price of CAN$0.355, which is equivalent to US$0.2814 at an exchange rate of 0.7925 as of the grant date.